Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
作者信息
Griebling Tomas L
出版信息
J Urol. 2014 Apr;191(4):1056. doi: 10.1016/j.juro.2014.01.058. Epub 2014 Jan 17.
PMID:24703136
Abstract
摘要
相似文献
1
Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
J Urol. 2014 Apr;191(4):1056. doi: 10.1016/j.juro.2014.01.058. Epub 2014 Jan 17.
2
Re: The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.
J Urol. 2013 Nov;190(5):1763-4. doi: 10.1016/j.juro.2013.07.082. Epub 2013 Aug 2.
3
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors.老年前列腺癌幸存者的尿失禁和排尿困扰负担。
Eur Urol. 2013 Oct;64(4):672-9. doi: 10.1016/j.eururo.2013.03.041. Epub 2013 Apr 3.
4
Characteristics and management of erectile dysfunction after various treatments for prostate cancer.前列腺癌各种治疗后勃起功能障碍的特征与管理
Int J Urol. 2010 Aug;17(8):689-97. doi: 10.1111/j.1442-2042.2010.02561.x. Epub 2010 Jun 29.
5
Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.局限性前列腺癌初始治疗后的长期健康相关生活质量：来自 CaPSURE 登记处的结果。
Eur Urol. 2015 Oct;68(4):600-8. doi: 10.1016/j.eururo.2014.08.074. Epub 2014 Sep 18.
6
Locally advanced prostate cancer: effective treatments, but many adverse effects.局部晚期前列腺癌：治疗有效，但不良反应众多。
Prescrire Int. 2013 Jan;22(134):18-20, 22-3.
7
Prostate Cancer Therapeutics and Their Complications: A Primer for the Primary Care Provider.前列腺癌治疗方法及其并发症：初级保健提供者指南
R I Med J (2013). 2020 Apr 1;103(3):41-45.
8
[Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness].
Vopr Onkol. 2009;55(3):285-90.
9
How to preserve potency and continence in localized prostate cancer.
BJU Int. 2007 Jul;100 Suppl 2:29-31. doi: 10.1111/j.1464-410X.2007.06950.x.
10
[Toxicity of multimodal regimens in prostate cancer].[前列腺癌多模式治疗方案的毒性]
Prog Urol. 2019 Jun;29 Suppl 1:S35-S41. doi: 10.1016/S1166-7087(19)30168-X.
Zotero 插件